title: Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.
authors.forename: M-J P L
authors.initials: MJ
authors.lastname: Stevens-Kroef
authors.forename: E F P M
authors.initials: EF
authors.lastname: Schoenmakers
authors.forename: M
authors.initials: M
authors.lastname: van Kraaij
authors.forename: E
authors.initials: E
authors.lastname: Huys
authors.forename: S
authors.initials: S
authors.lastname: Vermeulen
authors.forename: B
authors.initials: B
authors.lastname: van der Reijden
authors.forename: A Geurts
authors.initials: AG
authors.lastname: van Kessel
mesh_terms: D000208:Acute Disease; D002878:Chromosomes, Human, Pair 1; D002891:Chromosomes, Human, Pair 21; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000235:genetics*; D014158:Transcription, Genetic; D014178:Translocation, Genetic
chemical_list: D050676:Core Binding Factor Alpha 2 Subunit; D004268:DNA-Binding Proteins; D015514:Oncogene Proteins, Fusion; C416371:PRDM16 protein, human; C493728:RUNX1 protein, human; D014157:Transcription Factors